Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
29-30 March, 2025
Not Confirmed
Not Confirmed
31 March-01 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
29-30 March, 2025
Industry Trade Show
Not Confirmed
31 March-01 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
04 Jan 2024
// BUSINESSWIRE
26 Dec 2023
// INDIAN PHARMA POST
https://www.indianpharmapost.com/news/astellas-completes-acquisition-of-propella-therapeutics-15067
15 Nov 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/astellas-to-acquire-propella-therapeutics-301989842.html
14 Feb 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/02/14/2607588/0/en/Propella-Therapeutics-Announces-Presentation-of-Updated-Phase-1-2a-Data-of-PRL-02-for-the-Treatment-of-Advanced-Prostate-Cancer-at-2023-ASCO-Genitourinary-GU-Cancers-Symposium.html
08 Sep 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/09/08/2512425/0/en/Propella-Therapeutics-Announces-Presentation-of-Phase-1-2-Data-of-PRL-02-for-the-Treatment-of-Advanced-Prostate-Cancer-at-ESMO-Congress-2022.html
07 Apr 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/04/07/2418425/0/en/Propella-Therapeutics-Announces-Licensing-Agreement-with-Jiangsu-Aosaikang-Pharmaceutical-Co-Ltd-ASK-Pharm-for-Development-and-Commercial-Rights-to-CGS-200-5-in-Greater-China.html
ABOUT THIS PAGE